The Post-GWAS Era: How to Validate the Contribution of Gene Variants in Lupus
- PMID: 30673885
- DOI: 10.1007/s11926-019-0801-5
The Post-GWAS Era: How to Validate the Contribution of Gene Variants in Lupus
Abstract
Purpose of review: Systemic lupus erythematosus (SLE) is a complex autoimmune disease with strong genetic associations. Here, we provide an update on recent advancements in validating SLE candidate genes and risk variants identified in genome-wide association studies (GWAS).
Recent findings: A pairing of computational biology with new and emerging techniques has significantly increased our understanding of SLE associated variants. Specifically, generation of mutations within mice and examination of patient samples has been the dominant mechanisms for variant validation. While progress has been made in validating some genes, the number of associated genes is growing with minimal exploration of the effects of individual variants on SLE. This indicates that further examination of SLE risk variants in a cell-type-specific manner is required for better understanding of their contributions to SLE disease mechanisms.
Keywords: GWAS; Humanized mice; SLE; iPSC.
Similar articles
-
Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population.Rheumatology (Oxford). 2012 Jan;51(1):87-92. doi: 10.1093/rheumatology/ker263. Epub 2011 Oct 27. Rheumatology (Oxford). 2012. PMID: 22039224 Review.
-
Investigation of systemic lupus erythematosus (SLE) with integrating transcriptomics and genome wide association information.Gene. 2019 Jul 20;706:181-187. doi: 10.1016/j.gene.2019.05.004. Epub 2019 May 11. Gene. 2019. PMID: 31082500
-
Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus.PLoS Genet. 2011 Oct;7(10):e1002341. doi: 10.1371/journal.pgen.1002341. Epub 2011 Oct 27. PLoS Genet. 2011. PMID: 22046141 Free PMC article.
-
Association of interferon-induced helicase C domain (IFIH1) gene polymorphisms with systemic lupus erythematosus and a relevant updated meta-analysis.Genet Mol Res. 2016 Oct 24;15(4). doi: 10.4238/gmr15048008. Genet Mol Res. 2016. PMID: 27813554
-
Genetic susceptibility to SLE: recent progress from GWAS.J Autoimmun. 2013 Mar;41:25-33. doi: 10.1016/j.jaut.2013.01.008. Epub 2013 Feb 6. J Autoimmun. 2013. PMID: 23395425 Review.
Cited by
-
Identifying genetic variants that influence the abundance of cell states in single-cell data.Nat Genet. 2024 Oct;56(10):2068-2077. doi: 10.1038/s41588-024-01909-1. Epub 2024 Sep 26. Nat Genet. 2024. PMID: 39327486
-
Genetics of rheumatic fever and rheumatic heart disease.Nat Rev Cardiol. 2020 Mar;17(3):145-154. doi: 10.1038/s41569-019-0258-2. Epub 2019 Sep 13. Nat Rev Cardiol. 2020. PMID: 31519994 Review.
-
Genotype Triad for HOTAIR rs10783618, LINC-ROR rs1942347, and MALAT1 rs3200401 as Molecular Markers in Systemic Lupus Erythematous.Diagnostics (Basel). 2022 May 11;12(5):1197. doi: 10.3390/diagnostics12051197. Diagnostics (Basel). 2022. PMID: 35626352 Free PMC article.
-
Gene polymorphisms and serum levels of sVEGFR-1 in patients with systemic lupus erythematosus.Sci Rep. 2020 Sep 14;10(1):15031. doi: 10.1038/s41598-020-72020-8. Sci Rep. 2020. PMID: 32929141 Free PMC article.
-
Global discovery of lupus genetic risk variant allelic enhancer activity.Nat Commun. 2021 Mar 12;12(1):1611. doi: 10.1038/s41467-021-21854-5. Nat Commun. 2021. PMID: 33712590 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials